Patents
US 11980616 B2: Treating liver disease by selectively eliminating senescent cells
- Granted
- 2024-05-14
- Filed
- 2020-12-07 application 17114379
- Type
- Utility · 23 claims
- Elsewhere
- Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗
Abstract
Methods are provided herein for selectively killing senescent cells and for treating senescence-associated diseases and disorders by administering a senolytic agent. Senescence-associated diseases and disorders treatable by the methods using the senolytic agents described herein include cardiovascular diseases and disorders associated with or caused by arteriosclerosis, such as atherosclerosis; idiopathic pulmonary fibrosis; chronic obstructive pulmonary disease; osteoarthritis; senescence-associated ophthalmic diseases and disorders; and senescence-associated dermatological diseases and disorders.
Source: PVGPATDIS, file of 2026-04-10 (ipg240514.xml).
Assignees
| Assignee | Type | Place | Also on furp.org | Source |
|---|---|---|---|---|
| Mayo Foundation for Medical Education and Research 1,349 patents | US company or organization | Rochester, MN | PVGPATDIS, file of 2026-04-10 | |
| BUCK INSTITUTE FOR RESEARCH ON AGING 52 patents | US company or organization | Novato, CA | BUCK INSTITUTE FOR RESEARCH ON AGING Nonprofit EXACT high confidence: identical full name and state | PVGPATDIS, file of 2026-04-10 |
| Unity Biotechnology, Inc. 41 patents | US company or organization | Brisbane, CA | Unity Biotechnology, Inc. Form D issuer EXACT high confidence: identical full name and state UNITY BIOTECHNOLOGY, INC. SEC filer EXACT medium confidence: identical full name, one of each nationally | PVGPATDIS, file of 2026-04-10 |
Inventors
| Inventor | Place | Patents | Person page | Source |
|---|---|---|---|---|
| Remi-Martin Laberge | San Francisco, CA | 24 | PVGPATDIS, file of 2026-04-10 | |
| Judith Campisi | Berkeley, CA | 24 | PVGPATDIS, file of 2026-04-10 | |
| Marco Demaria | Groningen, NL | 20 | PVGPATDIS, file of 2026-04-10 | |
| Nathaniel David | Brisbane, CA | 41 | PVGPATDIS, file of 2026-04-10 | |
| James L. Kirkland | Rochester, MN | 22 | PVGPATDIS, file of 2026-04-10 | |
| Tamar Tchkonia | Rochester, MN | 21 | PVGPATDIS, file of 2026-04-10 | |
| Yi Zhu | Rochester, MN | 44 | PVGPATDIS, file of 2026-04-10 |
CPC categories
| Subclass | Category | First group | Source |
|---|---|---|---|
| A61K | Preparations for medical, dental or toiletry purposes | A61K31/496 | PVGPATDIS, file of 2026-04-10 |
| A61P | Specific therapeutic activity of chemical compounds or medicinal preparations | A61P9/10 | PVGPATDIS, file of 2026-04-10 |
| C12N | Microorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture media | C12N5/0081 | PVGPATDIS, file of 2026-04-10 |
| C12Q | Measuring or testing processes involving enzymes, nucleic acids or microorganisms ; compositions or test papers therefor; processes of preparing such compositions; condition-responsive control in microbiological or enzymological processes | C12Q1/485 | PVGPATDIS, file of 2026-04-10 |
Cooperative Patent Classification, as currently assigned (one row per subclass).
Assignments and security interests
| Recorded | What | From | To | Reel/frame | Source |
|---|---|---|---|---|---|
| 2023-10-26 | Government interest Confirmatory license | MAYO CLINIC ROCHESTER signed 2021-01-21 | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT BETHESDA, MD | 65379/678 | ECORSEXC, file of 2026-09-25 |
| 2021-02-23 | Assignment Assignment of assignor's interest | KIRKLAND, JAMES signed 2016-09-09 TCHKONIA, TAMAR signed 2016-09-09 ZHU, YI signed 2017-10-31 | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH ROCHESTER, MN | 55378/175 | ECORSEXC, file of 2026-09-25 |
| 2021-02-23 | Assignment Assignment of assignor's interest | DEMARIA, MARCO signed 2016-08-02 LABERGE, REMI-MARTIN signed 2016-08-02 CAMPISI, JUDITH signed 2016-08-03 | BUCK INSTITUTE FOR RESEARCH ON AGING NOVATO, CA | 55377/990 | ECORSEXC, file of 2026-09-25 |
| 2021-02-23 | Assignment Assignment of assignor's interest | DAVID, NATHANIEL signed 2016-08-02 | UNITY BIOTECHNOLOGY, INC. SAN FRANCISCO, CA | 55377/954 | ECORSEXC, file of 2026-09-25 |
Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.
USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.